Literature DB >> 18688655

A single-center study of C1q nephropathy in children.

Isabel Roberti1, Noosha Baqi, Shefali Vyas, Dae Un Kim.   

Abstract

C1q nephropathy (C1qN) is a rare idiopathic glomerulopathy typically seen in adolescents and young adults. All kidney biopsies done from 2002 to 2007 were analyzed (264). Thirteen cases of C1qN from 212 (6.6%) native biopsies and one case out of 52 (1.9%) transplant biopsies were reviewed regarding demographic features, clinical presentation, histopathology, treatment, and outcome. Age varied from 1 to 18 years; half were boys. Ten children (71.4%) presented with nephrotic syndrome (NS). The most common histopathology found was diffuse mesangial proliferative glomerulonephritis (DMP) by light microscopy (LM), with diffuse granular staining for C1q predominantly in the mesangium. Children with either NS or persistent gross hematuria received prednisone and angiotensin-converting enzyme inhibitors (ACEi) (11). Median follow-up was 36 months. Steroid response was complete in 6 patients (54.5%). Those with steroid resistance (5) or steroid dependence (2) received further immunosuppression with mycophenolate mofetil (MMF) or tacrolimus (Tac). Three children achieved complete remission and four partial remission. Frequent relapses were seen in 4/14 patients. Renal survival was 100%. Our report reveals a high incidence of C1qN in pediatric patients, with variable clinical presentation. Despite a high incidence of steroid resistance among those with NS, an excellent response was observed with the addition of further immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688655     DOI: 10.1007/s00467-008-0939-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  21 in total

1.  Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1996-10       Impact factor: 7.124

2.  Spontaneous improvement in a case of C1q nephropathy.

Authors:  M Nishida; H Kawakatsu; H Komatsu; K Ishiwari; M Tamai; T Sawada
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

Review 3.  Complement and glomerulonephritis: new insights.

Authors:  Daniel Turnberg; H Terence Cook
Journal:  Curr Opin Nephrol Hypertens       Date:  2005-05       Impact factor: 2.894

Review 4.  Complement in lupus nephritis: the good, the bad, and the unknown.

Authors:  Lihua Bao; Richard J Quigg
Journal:  Semin Nephrol       Date:  2007-01       Impact factor: 5.299

5.  Nonsystemic mesangiopathic glomerulonephritis with "full house" immunofluorescence. Pathological and clinical observation in five patients.

Authors:  E Jones; A Magil
Journal:  Am J Clin Pathol       Date:  1982-07       Impact factor: 2.493

6.  Distinguishing C1q nephropathy from lupus nephritis.

Authors:  Andrew Sharman; Peter Furness; John Feehally
Journal:  Nephrol Dial Transplant       Date:  2004-03-05       Impact factor: 5.992

7.  A case of congenital nephrotic syndrome associated with positive C1q immunofluorescence.

Authors:  M Kuwano; Y Ito; Y Amamoto; K Aida
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

8.  Clinicopathologic correlation of C1q nephropathy in children.

Authors:  Yuko Fukuma; Satoshi Hisano; Yoshie Segawa; Kazuhiko Niimi; Noboru Tsuru; Yoshitsugu Kaku; Ken Hatae; Yasuhiro Kiyoshi; Akihisa Mitsudome; Hiroshi Iwasaki
Journal:  Am J Kidney Dis       Date:  2006-03       Impact factor: 8.860

9.  C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome.

Authors:  J C Jennette; C G Hipp
Journal:  Am J Kidney Dis       Date:  1985-08       Impact factor: 8.860

10.  Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens.

Authors:  J C Jennette; C G Hipp
Journal:  Am J Clin Pathol       Date:  1985-04       Impact factor: 2.493

View more
  5 in total

1.  Change in C1q deposition in C1q nephropathy.

Authors:  Kazunari Kaneko; Masafumi Hasui; Ken Hatae; Hidenori So; Ritsuko Katafuchi
Journal:  Pediatr Nephrol       Date:  2009-03-14       Impact factor: 3.714

Review 2.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

3.  C1q nephropathy in a child presenting with recurrent gross hematuria.

Authors:  Luke Taggart; Alexis Harris; Samir El-Dahr; Franca Iorember
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

4.  C1q nephropathy: a true immune complex disease or an immunologic epiphenomenon?

Authors:  Mordi Muorah; Manish D Sinha; Catherine Horsfield; Patrick J O'Donnell
Journal:  NDT Plus       Date:  2009-05-09

5.  C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics.

Authors:  Kipyo Kim; Hyung-Eun Son; Ji-Young Ryu; Hajeong Lee; Seung Hyeok Han; Dong-Ryeol Ryu; Jin Ho Paik; Sejoong Kim; Ki Young Na; Dong-Wan Chae; Ho Jun Chin; Se Won Oh
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.